Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
PUT
Trex
TREX
$4.66B
| $236K | ﹤0.01% |
5,200
| – | – |
|
|
ODT
4752
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $236K | ﹤0.01% |
9,109
+1,632
| +22% | +$54.6K |
|
|
VIA
4753
DELISTED
Viacom Inc. Class A
VIA
| $236K | ﹤0.01% |
9,050
-545
| -6% | -$16.9K |
|
4754
Telkom Indonesia
TLK
$15B
| $235K | ﹤0.01% |
7,774
-3,567
| -31% | -$108K |
|
4755
CALL
Direxion Daily Technology Bear 3x ETF
TECS
$66.3M
| $234K | ﹤0.01% |
2
+1
| +100% | +$115K |
|
4756
Viking Therapeutics
VKTX
$3.8B
| $234K | ﹤0.01% |
34,020
-28,509
| -46% | -$212K |
|
|
CONN
4757
PUT
DELISTED
Conn's Inc.
CONN
| $234K | ﹤0.01% |
9,400
+1,500
| +19% | +$31.5K |
|
|
SCPL
4758
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $234K | ﹤0.01% |
21,823
+11,423
| +110% | +$125K |
|
|
ASRT
4759
DELISTED
Assertio
ASRT
| $233K | ﹤0.01% |
3,024
-455
| -13% | -$59.2K |
|
4760
Standard BioTools
LAB
$339M
| $233K | ﹤0.01% |
50,198
+2,645
| +6% | +$20.8K |
|
|
APRN
4761
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $233K | ﹤0.01% |
2,300
+1,261
| +121% | +$123K |
|
4762
CALL
Hormel Foods
HRL
$13.9B
| $232K | ﹤0.01% |
5,300
+3,400
| +179% | +$143K |
|
4763
Quad
QUAD
$559M
| $232K | ﹤0.01% |
22,079
-70,791
| -76% | -$662K |
|
4764
Utah Medical Products
UTMD
$232M
| $232K | ﹤0.01% |
2,423
-1,524
| -39% | -$142K |
|
4765
Carriage Services
CSV
$645M
| $231K | ﹤0.01% |
11,275
-2,731
| -19% | -$56.7K |
|
|
ABMD
4766
PUT
DELISTED
Abiomed Inc
ABMD
| $231K | ﹤0.01% |
1,300
-29,700
| -96% | -$6.42M |
|
|
OXFD
4767
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $231K | ﹤0.01% |
13,875
-91,512
| -87% | -$1.27M |
|
|
BLUE
4768
PUT
DELISTED
bluebird bio
BLUE
| $230K | ﹤0.01% |
193
+77
| +66% | +$118K |
|
|
SA
4769
Seabridge Gold
SA
$2.84B
| $230K | ﹤0.01% |
18,126
-13,952
| -43% | -$198K |
|
|
SLCA
4770
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $230K | ﹤0.01% |
24,100
-8,200
| -25% | -$94.5K |
|
|
HCR
4771
CALL
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $230K | ﹤0.01% |
132,000
-30,000
| -19% | -$57.6K |
|
|
REV
4772
CALL
DELISTED
Revlon, Inc.
REV
| $230K | ﹤0.01% |
+9,800
| New | +$185K |
|
4773
PUT
Pitney Bowes
PBI
$2.48B
| $229K | ﹤0.01% |
50,000
+500
| +1% | +$2K |
|
|
SNV
4774
PUT
DELISTED
Synovus
SNV
| $229K | ﹤0.01% |
6,400
+1,600
| +33% | +$57.4K |
|
4775
PUT
Terex
TEX
$7.36B
| $229K | ﹤0.01% |
8,800
+6,700
| +319% | +$184K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.